Trial Profile
Efficacy of axitinib in renal cell carcinoma: Real-world experience at Gustave Roussy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Axitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 01 Sep 2015 New trial record